WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Melissa B. EpperlyDirector2026-10-01900$36.57
$32.91kSell
Melissa B. EpperlyDirector2026-10-0117,750$4.46
$79.17kBuy
Melissa B. EpperlyDirector2026-10-0116,850$36.08
$607.95kSell
Eric VenkerDivCEO;Pres2026-09-30200,000$36.62
$7.32MSell
Eric VenkerDivCEO;Pres2026-09-30200,000$3.85
$770.00kBuy
Matthew GlineCEO2026-09-3076,171$36.57
$2.79MSell
Frank TortiChair;Pres2026-09-3040,309$36.57
$1.47MSell
Mayukh SukhatmePres;CIO2026-09-3046,879$36.57
$1.71MSell
Jennifer HumesCAO2026-09-203,880$39.77
$154.31kSell
Richard PulikCFO2026-09-202,129$39.77
$84.67kSell

1 of 22

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Qvt Financial LP15.76%113,830,063$4.07BInsider
Daniel Allen Gold14.80%106,895,394$3.82BInsider
Dexcel Pharma Technologies Ltd14.24%102,849,443$3.68BInsider
Svf Investments Uk Ltd10.11%73,031,667$2.61BInsider
Keith S. Manchester9.90%71,534,465$2.56BInsider
Sumitomo Chemical Co Ltd9.86%71,251,083$2.55BInsider
Vivek Ramaswamy6.51%47,011,612$1.68BInsider
Mayukh Sukhatme2.80%20,241,558$724.24MInsider
Matthew Gline2.30%16,583,774$593.37MInsider
Frank Torti1.87%13,495,893$482.88MInsider

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV0.08%92.22%Net SellingNet Selling
BNTX0.02%31.66%Net SellingNet Selling
GMAB0.16%0.00%
UTHR0.10%14.82%Net SellingNet Selling
INSM0.10%17.38%Net SellingNet Selling
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 0.08% institutional shareholders, 92.22% Roivant Sciences insiders, and 7.70% retail investors. Qvt Financial LP is the largest individual Roivant Sciences shareholder, owning 113.83M shares representing 15.76% of the company. Qvt Financial LP's Roivant Sciences shares are currently valued at $4.04B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.